Selective Laser Photocoagulation of Communicating Vessels in Twin-Twin Transfusion Syndrome

CompletedOBSERVATIONAL
Enrollment

77

Participants

Timeline

Start Date

October 31, 2006

Primary Completion Date

February 28, 2009

Study Completion Date

February 28, 2009

Conditions
Twin Twin Transfusion Syndrome
Interventions
DEVICE

Selective Laser Photocoagulation of Communicating Vessels

Patients will be admitted to Tampa General Hospital. Laboratory tests and anesthesia assessments will be completed. Antibiotic prophylaxis is initiated within an hour of surgery and continued every 8 hours through the first post-operative day. Surgery will be performed preferably under local anesthesia for the mother using 1% xylocaine with epinephrine at the trocar entry site, and IV sedation. Surgery will be performed with standard operative fetoscopy equipment and techniques. A trocar will be introduced in the amniotic cavity of the recipient. An amniotic fluid sample will be obtained for microbiological studies, and genetic analysis for clinical care only. The amniotic fluid will be discarded after analysis. The communicating vessels will be located endoscopically and will be lasered with YAG laser energy. The procedure will be monitored both endoscopically and sonographically. The presence of fetal heart activity will be noted. An amniodrainage of the larger sac may be performed

Trial Locations (1)

33606

University of South Florida, Tampa

All Listed Sponsors
lead

University of South Florida

OTHER

NCT01622049 - Selective Laser Photocoagulation of Communicating Vessels in Twin-Twin Transfusion Syndrome | Biotech Hunter | Biotech Hunter